Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 08 08 2021
accepted: 03 09 2021
entrez: 14 10 2021
pubmed: 15 10 2021
medline: 25 2 2023
Statut: epublish

Résumé

Current knowledge on Multiple Sclerosis (MS) etiopathogenesis encompasses complex interactions between the host's genetic background and several environmental factors that result in dysimmunity against the central nervous system. An old-aged association exists between MS and viral infections, capable of triggering and sustaining neuroinflammation through direct and indirect mechanisms. The novel Coronavirus, SARS-CoV-2, has a remarkable, and still not fully understood, impact on the immune system: the occurrence and severity of both acute COVID-19 and post-infectious chronic illness (long COVID-19) largely depends on the host's response to the infection, that echoes several aspects of MS pathobiology. Furthermore, other MS-associated viruses, such as the Epstein-Barr Virus (EBV) and Human Endogenous Retroviruses (HERVs), may enhance a mechanistic interplay with the novel Coronavirus, with the potential to interfere in MS natural history. Studies on COVID-19 in people with MS have helped clinicians in adjusting therapeutic strategies during the pandemic; similar efforts are being made for SARS-CoV-2 vaccination campaigns. In this Review, we look over 18 months of SARS-CoV-2 pandemic from the perspective of MS: we dissect neuroinflammatory and demyelinating mechanisms associated with COVID-19, summarize pathophysiological crossroads between MS and SARS-CoV-2 infection, and discuss present evidence on COVID-19 and its vaccination in people with MS.

Identifiants

pubmed: 34646278
doi: 10.3389/fimmu.2021.755333
pmc: PMC8503550
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

755333

Informations de copyright

Copyright © 2021 Bellucci, Rinaldi, Buscarinu, Reniè, Bigi, Pellicciari, Morena, Romano, Marrone, Mechelli, Salvetti and Ristori.

Déclaration de conflit d'intérêts

MS received research support and consulting fees from Biogen, Merck, Novartis, Roche, Sanofi, Teva. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Acta Neuropathol Commun. 2020 Feb 3;8(1):9
pubmed: 32014066
Science. 1980 Aug 22;209(4459):933-4
pubmed: 7403860
Mult Scler. 2013 Oct;19(11):1526-32
pubmed: 23439577
J Clin Virol. 2000 May;16(3):179-91
pubmed: 10738137
Mult Scler Relat Disord. 2020 Sep;44:102324
pubmed: 32615528
Front Immunol. 2021 Jun 21;12:701752
pubmed: 34234787
Br J Dermatol. 2021 Jun;184(6):1187-1190
pubmed: 33420720
Neurol Neuroimmunol Neuroinflamm. 2020 Jul 1;7(5):
pubmed: 32611761
Neurology. 2020 Dec 15;95(24):e3373-e3385
pubmed: 32934172
Acta Neuropathol. 2020 Jul;140(1):1-6
pubmed: 32449057
Nat Rev Immunol. 2020 Jun;20(6):345-346
pubmed: 32358580
Med Hypotheses. 2020 Jul;140:109759
pubmed: 32344305
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2040-5
pubmed: 21245328
Immunity. 2020 Jun 16;52(6):905-909
pubmed: 32497522
J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
PLoS One. 2013 May 16;8(5):e63300
pubmed: 23696811
Lancet Neurol. 2020 Jun;19(6):481-482
pubmed: 32359409
Neurol Neuroimmunol Neuroinflamm. 2021 May 20;8(4):
pubmed: 34016734
Mult Scler Relat Disord. 2019 Apr;29:26-34
pubmed: 30658261
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
J Neuroimmunol. 2020 Dec 15;349:577405
pubmed: 33002725
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Lancet. 2020 May 30;395(10238):1695-1704
pubmed: 32401715
Neurol Neuroimmunol Neuroinflamm. 2021 Jul 28;8(5):
pubmed: 34321333
Mult Scler Relat Disord. 2021 Jul;52:102939
pubmed: 34010764
Inflamm Bowel Dis. 2020 Aug 20;26(9):1306-1314
pubmed: 32720978
Neurol Neuroimmunol Neuroinflamm. 2020 Jul 9;7(5):
pubmed: 32646885
Virology. 1992 Nov;191(1):502-5
pubmed: 1413524
Autoimmun Rev. 2021 May;20(5):102803
pubmed: 33737090
Brain. 2020 Oct 1;143(10):3104-3120
pubmed: 32637987
J Child Neurol. 2017 Oct;32(12):996-999
pubmed: 28820014
Infect Dis Now. 2021 May;51(3):296-299
pubmed: 33495765
Nat Rev Immunol. 2015 Sep 15;15(9):545-58
pubmed: 26250739
Lancet Neurol. 2015 Mar;14(3):263-73
pubmed: 25662901
J Virol. 2000 Oct;74(19):8913-21
pubmed: 10982334
Sci Adv. 2017 Jul 12;3(7):e1700492
pubmed: 28706993
Cell. 2020 Oct 1;183(1):16-27.e1
pubmed: 32882182
Lancet Neurol. 2017 Jun;16(6):413-414
pubmed: 28504102
Neuron. 2018 Feb 21;97(4):742-768
pubmed: 29470968
Lancet Neurol. 2020 Sep;19(9):713-715
pubmed: 32822622
Ther Adv Neurol Disord. 2021 Apr 22;14:17562864211012835
pubmed: 34035836
J Virol. 2020 Nov 9;94(23):
pubmed: 32938761
Ann Clin Transl Neurol. 2014 Jul;1(7):502-11
pubmed: 25356421
Front Immunol. 2019 Apr 16;10:796
pubmed: 31057538
Int J Mol Sci. 2020 Nov 03;21(21):
pubmed: 33153042
Nat Rev Immunol. 2020 Jul;20(7):397-398
pubmed: 32457522
EBioMedicine. 2021 Apr;66:103341
pubmed: 33867312
J Neurol. 2021 Jul;268(7):2327-2330
pubmed: 32940797
Radiology. 2020 Aug;296(2):E119-E120
pubmed: 32228363
Neurol Neuroimmunol Neuroinflamm. 2016 Jan 07;3(1):e190
pubmed: 26770996
Science. 2020 Nov 13;370(6518):861-865
pubmed: 33082294
Biochim Biophys Acta. 2011 Feb;1812(2):132-40
pubmed: 20600868
Immunity. 2011 Feb 25;34(2):213-23
pubmed: 21349431
Cell Rep Med. 2021 Jul 20;2(7):100355
pubmed: 34230917
Autoimmun Rev. 2021 Sep;20(9):102888
pubmed: 34229045
Immunity. 2021 Jul 13;54(7):1594-1610.e11
pubmed: 34174183
Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744
pubmed: 34240579
Ann Intern Med. 1985 Jan;102(1):7-16
pubmed: 2578268
Nat Commun. 2015 Feb 11;6:6240
pubmed: 25670642
Autoimmun Rev. 2020 Oct;19(10):102647
pubmed: 32801039
Nat Commun. 2020 Jul 6;11(1):3434
pubmed: 32632085
Neuroepidemiology. 2015;45(2):83-9
pubmed: 26316226
Mult Scler. 2021 May;27(6):864-870
pubmed: 33856242
Auto Immun Highlights. 2019 Nov 15;10(1):12
pubmed: 32257068
Mult Scler. 2019 Jun;25(7):891-901
pubmed: 30638421
Mult Scler Relat Disord. 2021 Jul;52:102983
pubmed: 33990054
Mult Scler Relat Disord. 2021 Sep;54:103150
pubmed: 34298478
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Clin Pract Cases Emerg Med. 2020 Aug;4(3):321-323
pubmed: 32926676
Brain. 2007 Apr;130(Pt 4):1089-104
pubmed: 17438020
Cell Rep. 2020 Sep 22;32(12):108175
pubmed: 32946807
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Brain Pathol. 2004 Apr;14(2):164-74
pubmed: 15193029
Front Immunol. 2015 Oct 19;6:520
pubmed: 26539193
Br J Hosp Med (Lond). 2020 Sep 2;81(9):1-3
pubmed: 32990089
Science. 2021 Aug 20;373(6557):931-936
pubmed: 34285133
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Nature. 2020 Nov;587(7833):197
pubmed: 33173222
Mult Scler. 2021 Mar;27(3):347-359
pubmed: 32940128
Mult Scler Relat Disord. 2021 May;50:102863
pubmed: 33662859
Eur J Neurol. 2021 Oct;28(10):3384-3395
pubmed: 33340215
Front Immunol. 2019 Nov 26;10:2715
pubmed: 32038605
Neurology. 2006 Aug 22;67(4):652-9
pubmed: 16870812
Eur J Immunol. 2014 Oct;44(10):3119-28
pubmed: 25043505
Neurol Sci. 2021 Sep;42(9):3523-3526
pubmed: 34128150
Neurol Neuroimmunol Neuroinflamm. 2020 Jun 1;7(5):
pubmed: 32482781
JAMA Neurol. 2014 Dec;71(12):1506-13
pubmed: 25329096
Clin Transl Immunology. 2017 Jan 20;6(1):e126
pubmed: 28197337
Cytokine Growth Factor Rev. 2015 Apr;26(2):221-8
pubmed: 25466632
Cell. 2020 Nov 12;183(4):968-981.e7
pubmed: 32966765
Sci Rep. 2019 Aug 7;9(1):11464
pubmed: 31391529
Ann Intern Med. 1994 Dec 15;121(12):953-9
pubmed: 7978722
Trends Mol Med. 2020 Mar;26(3):296-310
pubmed: 31862243
J Neurol. 1995 Feb;242(3):143-6
pubmed: 7751856
Ann Clin Transl Neurol. 2020 Nov;7(11):2221-2230
pubmed: 33016619
Lancet. 1991 Jun 1;337(8753):1346-7
pubmed: 1674318
Front Immunol. 2021 Jan 26;11:618544
pubmed: 33574821
Brain. 2011 Feb;134(Pt 2):542-54
pubmed: 21216829
EBioMedicine. 2021 Oct;72:103581
pubmed: 34563483
Cytol Genet. 2020;54(6):588-604
pubmed: 33487779
Mult Scler Relat Disord. 2020 Nov;46:102540
pubmed: 33032060
Nat Med. 2021 Nov;27(11):1990-2001
pubmed: 34522051
Sleep. 2010 Aug;33(8):1061-7
pubmed: 20815187
J Virol. 2019 Nov 26;93(24):
pubmed: 31578295
Lancet Neurol. 2021 Jan;20(1):38-48
pubmed: 33242419
N Engl J Med. 2021 May 13;384(19):1866-1868
pubmed: 33761203
J Neurol. 2022 Jan;269(1):55-58
pubmed: 34115170
J Neurol Sci. 2020 Dec 15;419:117179
pubmed: 33070003
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Neuroradiology. 2021 May;63(5):653-661
pubmed: 33575849
Int J Mol Sci. 2019 Jul 29;20(15):
pubmed: 31362360
PLoS One. 2015 Apr 08;10(4):e0119605
pubmed: 25853421
J Neurol Neurosurg Psychiatry. 1998 Jun;64(6):736-41
pubmed: 9647301
Front Immunol. 2020 Jun 26;11:1580
pubmed: 32670297
J Neurol. 2022 Jan;269(1):39-43
pubmed: 34189719
J Virol. 2021 Jun 10;95(13):e0019221
pubmed: 33853968
Brain Behav Immun. 2021 Mar;93:415-419
pubmed: 33359380
Cell Rep. 2020 Oct 6;33(1):108234
pubmed: 32979938
Trends Mol Med. 2021 Sep;27(9):895-906
pubmed: 34175230
Cell Rep. 2021 May 11;35(6):109112
pubmed: 33979622
Clin Infect Dis. 1995 Nov;21(5):1204-10
pubmed: 8589144
Trends Neurosci. 2020 Aug;43(8):622-634
pubmed: 32650957
Nat Rev Immunol. 2020 May;20(5):269-270
pubmed: 32273594
Mult Scler Relat Disord. 2020 Oct;45:102377
pubmed: 32698095
N Engl J Med. 2001 Feb 1;344(5):319-26
pubmed: 11172162
Sci Immunol. 2021 May 25;6(59):
pubmed: 34035118
J Neuroimmunol. 2021 Apr 15;353:577521
pubmed: 33607505
Mol Neurobiol. 2018 Apr;55(4):3592-3609
pubmed: 28516431
Neurol Neuroimmunol Neuroinflamm. 2020 May 26;7(5):
pubmed: 32457227
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Neurologist. 2009 Jan;15(1):1-5
pubmed: 19131851
Acta Neurochir (Wien). 2020 Jul;162(7):1491-1494
pubmed: 32367205
Mult Scler. 2022 Mar;28(3):429-440
pubmed: 34240656
Curr Opin Neurol. 2021 Jun 1;34(3):322-328
pubmed: 33709979
eNeurologicalSci. 2021 Mar;22:100299
pubmed: 33313429
J Neuroophthalmol. 2020 Sep;40(3):398-402
pubmed: 32604245
Front Immunol. 2021 Apr 26;12:653786
pubmed: 33981305
J Cell Sci. 2016 Oct 15;129(20):3911-3921
pubmed: 27591257
JAMA Neurol. 2020 Jan 1;77(1):58-64
pubmed: 31515562
Mult Scler Relat Disord. 2021 Apr;49:102783
pubmed: 33513521
J Neuroimmune Pharmacol. 2010 Sep;5(3):271-7
pubmed: 20369303
F1000Res. 2020 Aug 17;9:992
pubmed: 33456761
BMC Med. 2013 Sep 17;11:205
pubmed: 24229326
Ann Intern Med. 1985 Jan;102(1):1-7
pubmed: 2578266
Eur J Neurol. 2021 Nov;28(11):3742-3748
pubmed: 34288285
JAMA Neurol. 2015 May;72(5):605
pubmed: 25961176
Mult Scler Relat Disord. 2020 Jul;42:102201
pubmed: 32480327
Crit Care. 2020 Nov 23;24(1):657
pubmed: 33228750
Nat Rev Neurol. 2021 Aug;17(8):515-521
pubmed: 34155379
Cell. 2020 Nov 12;183(4):982-995.e14
pubmed: 32991843
Gastroenterology. 2020 Sep;159(3):944-955.e8
pubmed: 32442562
PLoS Pathog. 2013;9(4):e1003220
pubmed: 23592979
Mult Scler Relat Disord. 2021 Jul;52:103014
pubmed: 34000684
Virol J. 2017 Feb 28;14(1):42
pubmed: 28241767
J Neurol Sci. 2020 Nov 15;418:117146
pubmed: 32977227
Brain. 2020 May 1;143(5):1414-1430
pubmed: 32282893
Eur J Neurol. 2019 Jul;26(7):1032-1036
pubmed: 30714270
Front Immunol. 2020 Jun 23;11:1518
pubmed: 32655582
J Neurol. 2021 Nov;268(11):3961-3968
pubmed: 33844056
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Sci Rep. 2021 May 25;11(1):10902
pubmed: 34035353
Science. 2021 Jan 8;371(6525):145-153
pubmed: 33414215
Rev Neurol (Paris). 2006 Mar;162(3):311-20
pubmed: 16585886
Neurology. 2020 Oct 6;95(14):e1999-e2008
pubmed: 32727835
Nat Rev Neurol. 2019 Dec;15(12):689-690
pubmed: 31654040
Front Immunol. 2020 Jun 18;11:1459
pubmed: 32655578
Neurol Sci. 2020 Nov;41(11):3023-3026
pubmed: 32876775
Science. 2021 Feb 12;371(6530):741-745
pubmed: 33436525
NeuroRehabilitation. 2014;35(3):529-34
pubmed: 25238862
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Mult Scler Relat Disord. 2021 Jun;51:102915
pubmed: 33799284
Microorganisms. 2021 May 24;9(6):
pubmed: 34074025
Cell Host Microbe. 2020 Jun 10;27(6):879-882.e2
pubmed: 32359396
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
Rev Neurol (Paris). 2021 Dec;177(10):1237-1240
pubmed: 34172292
N Engl J Med. 2001 Jun 7;344(23):1794; author reply 1795-6
pubmed: 11396455
Cell Rep Med. 2021 May 18;2(5):100288
pubmed: 33969321
Nature. 2021 Jul;595(7868):565-571
pubmed: 34153974
Brain. 2002 May;125(Pt 5):952-60
pubmed: 11960885
Travel Med Infect Dis. 2021 Mar-Apr;40:102000
pubmed: 33640477
Mult Scler. 2021 May;27(6):973-976
pubmed: 32909895
Science. 2020 Dec 4;370(6521):
pubmed: 33060197
Mult Scler Relat Disord. 2020 Jul;42:102120
pubmed: 32315980

Auteurs

Gianmarco Bellucci (G)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Virginia Rinaldi (V)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Maria Chiara Buscarinu (MC)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.
Neuroimmunology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, Rome, Italy.

Roberta Reniè (R)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Rachele Bigi (R)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Giulia Pellicciari (G)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Emanuele Morena (E)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Carmela Romano (C)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Antonio Marrone (A)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Rosella Mechelli (R)

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Pisana, Rome, Italy.
San Raffaele Roma Open University, Rome, Italy.

Marco Salvetti (M)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Italy.

Giovanni Ristori (G)

Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.
Neuroimmunology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH